A dendrimer-based prodrug for use in an anti-cancer nanocell
Thesis (M. Eng.)--Massachusetts Institute of Technology, Biological Engineering Division, 2007. === Includes bibliographical references. === Cancer science is a heavily researched and rapidly changing field. Cutting edge research consistently reveals unique features of tumors that can be exploited f...
Main Author: | Awasthi, Samir |
---|---|
Other Authors: | Ram Sasisekharan and Shiladitya Sengupta. |
Format: | Others |
Language: | English |
Published: |
Massachusetts Institute of Technology
2008
|
Subjects: | |
Online Access: | http://hdl.handle.net/1721.1/39922 |
Similar Items
-
In silico analysis of hypoxia activated prodrugs in combination with anti angiogenic therapy through nanocell delivery.
by: Cameron Meaney, et al.
Published: (2020-05-01) -
Dendrimer Prodrugs
by: Soraya da Silva Santos, et al.
Published: (2016-05-01) -
Yeast-based vaccine approaches to cancer immunotherapy
by: Howland, Shanshan W
Published: (2009) -
Programming the nanocell, a random array of molecules
by: Husband, Summer Michele
Published: (2009) -
Regulation of apoptosis in human cancer cells
by: Lloyd, S. Julie-Ann (Simone Julie-Ann)
Published: (2006)